From the CME Institute

Christoph U. Correll, MD

Brief Report | Earn 1.00 Credit
(Expires 03/31/2022)

Current Treatment Options and Emerging Agents for Schizophrenia

Christoph U. Correll, MD

Brief Report | Earn 1.00 Credit
(Expires 03/31/2022)

Using Patient-Centered Assessment in Schizophrenia Care: Defining Recovery and Discussing Concerns and Preferences

John Lauriello, MD

Brief Report | Earn 0.50 Credit
(Expires 03/31/2022)

Prevalence and Impact of Relapse in Patients With Schizophrenia

Madhukar H. Trivedi, MD

Brief Report | Earn 0.50 Credit
(Expires 03/31/2022)

How Can Measurement-Based Care Help Improve Treatment Outcomes for Major Depressive Disorder in Primary Care?

Madhukar H. Trivedi, MD

Brief Report | Earn 0.50 Credit
(Expires 03/31/2022)

Major Depressive Disorder in Primary Care: Strategies for Identification

Leslie L. Citrome, MD, MPH

Brief Report | Earn 0.50 Credit
(Expires 01/31/2022)

Medication Options and Clinical Strategies for Treating Tardive Dyskinesia

Stephen R. Saklad, PharmD, BCPP

Brief Report | Earn 0.50 Credit
(Expires 12/31/2021)

Identifying Tardive Dyskinesia: Risk Factors, Functional Impact, and Diagnostic Tools

Trisha Suppes, MD, PhD

Brief Report | Earn 0.50 Credit
(Expires 12/31/2021)

Strategies for Shifting From Acute to Maintenance Treatment for Bipolar I Disorder

Stuart H. Isaacson, MD

Brief Report | Earn 1.00 Credit
(Expires 12/31/2021)

Effective Treatment Strategies for Motor and Nonmotor Symptoms of Parkinson Disease

Stuart H. Isaacson, MD

Brief Report | Earn 0.50 Credit
(Expires 12/31/2021)

Early Recognition and Diagnosis of Parkinson Disease and Ongoing Assessments

Trisha Suppes, MD, PhD

Brief Report | Earn 0.50 Credit
(Expires 12/31/2021)

Evidence-Based Treatment Targets, Selection, and Strategies for Acute Manic and Mixed Episodes of Bipolar I Disorder

Daniel E. Kremens, MD, JD

Brief Report | Earn 0.50 Credit
(Expires 11/30/2021)

Treatment Strategies for Tardive Dyskinesia

Daniel E. Kremens, MD, JD

Brief Report | Earn 0.50 Credit
(Expires 11/30/2021)

Earlier Diagnosis of Tardive Dyskinesia

Joseph P. McEvoy, MD

Brief Report | Earn 0.50 Credit
(Expires 11/30/2021)

FDA-Approved Medications to Treat Tardive Dyskinesia

Joseph P. McEvoy, MD

Brief Report | Earn 0.50 Credit
(Expires 10/31/2021)

Psychosocial Implications of Tardive Dyskinesia in Patients With Mood Disorders Versus Schizophrenia

More ways to earn credit

The Official Journal of The American Society of Clinical Psychopharmacology

JCP Weekly

Clinical and Practical Psychopharmacology

Antidepressant Prescription in Pregnancy: The Importance of Prenatal Maternal Anemia as a Potential Confound in Studies on Neurodevelopmental and Other Outcomes [Free]

J Clin Psychiatry 2020;81(2):20f13347

Original Research

Evaluation of Cardiometabolic Risk in a Large Psychiatric Cohort and Comparison With a Population-Based Sample in Switzerland

J Clin Psychiatry 2020;81(3):19m12796

Review Article | Earn Credit

New-Onset Delusions Heralding an Underlying Neurodegenerative Condition: A Case Report and Review of the Literature

J Clin Psychiatry 2020;81(2):19r13027

Editorial

COVID-19 From a Psychiatry Perspective: Meeting the Challenges [Free]

J Clin Psychiatry 2020;81(2):20ed13358

Commentary

COVID-19 Diary From a Psychiatry Department in Italy [Free]

J Clin Psychiatry 2020;81(3):20com13357

Commentary

A Viewpoint From Paris on the COVID-19 Pandemic: A Necessary Turn to Telepsychiatry [Free]

J Clin Psychiatry 2020;81(3):20com13361

Clinical and Practical Psychopharmacology

The Use and Limitations of the Fragility Index in the Interpretation of Clinical Trial Findings

J Clin Psychiatry 2020;81(2):20f13334

Original Research

Metabolic Effects of 7 Antipsychotics on Patients With Schizophrenia: A Short-Term, Randomized, Open-Label, Multicenter, Pharmacologic Trial

J Clin Psychiatry 2020;81(3):19m12785

See all JCP Weekly

Did you know?

Find out more

Blog

Let's Talk Blog

Browse by Topic